Prospective value of the Genea natural killer cell activity (NKa) blood test and its extended panels on live birth rate in women under 40 years doing In vitro fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) or frozen embryo transfer cycles.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2026
This article has no abstract
Epistemonikos ID: fa21568727e60d15798524adbc852734658aa6d3
First added on: Jul 28, 2026